Fig. 4
CBMN assay data, expressed as the % of micronuclei in 1000 binucleated lymphocytes for 4 individuals in each treatment group with mean and SD. The data denoted by * and ** are significantly different from the BLM treated group. The level of significance was Pā<ā0.05